Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics designed to restore synapses to improve health in the lives of patients, presented initial positive ...
What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback